SCHEMBL9046532

SCHEMBL9046532

O=C(C1Cc2ccccc2C1)C1CCN[C@H]1C(=O)N1CCC[C@H]1C=NO

nearest known ligand 0.34

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PREP P48147 10/20 0.33
F2 P00734 1/20 0.32
DPP4 P27487 1/20 0.32
FAP Q12884 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
ADAM10 O14672 1/20 0.31
ERBB2 P04626 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
RIPK1 Q13546 1/20 0.31
KEAP1 Q14145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9171249 0.95 F2 (0.36) PREPF2
SCHEMBL9046423 0.85 PREP (0.42) PREP
SCHEMBL9047509 0.84 PREP (0.39) PREP
SCHEMBL9046318 0.84 PREP (0.37) PREPHRH3
SCHEMBL9047409 0.83 PREP (0.45) PREP
SCHEMBL9048722 0.81 PREP (0.39) PREPF2
SCHEMBL9046521 0.81 PREP (0.32) PREPF2DPP4FAPDPP8
SCHEMBL9048348 0.80 PREP (0.36) PREPKEAP1
SCHEMBL9049967 0.80 PREP (0.37) PREP
SCHEMBL9050548 0.79 DPP4 (0.53) PREPDPP4FAPDPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed